# Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease

> **NCT02231320** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 236 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Berodual® Respimat® - inhaler

## Key facts

- **NCT ID:** NCT02231320
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2006-06
- **Final completion:** —
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2014-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02231320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02231320, "Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02231320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*